Business
10x Genomics Showcases Robust Innovation Pipeline at Xperience 2022 Event
New technology reveals include first data from upcoming Xenium In Situ Analysis Platform PLEASANTON, Calif,, Feb. 22, 2022 /PRNewswire/ -- 10x Genomics, Inc.
About this update from 10x Genomics, Inc.
[{"type":"text","content":"New technology reveals include first data from upcoming Xenium In Situ Analysis Platform\n\n\nPLEASANTON, Calif,, Feb. 22, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today unveiled new details about upcoming products and capabilities across its single cell, spatial, and in situ platforms at its second annual Xperience 2022 virtual event. Highlights included the Fixed RNA Profiling Kit, which improves sample preparation workflow and adds flexibility for Chromium single cell experiments; Visium CytAssist, to expand the number of tissue samples accessible to the spatial platform; and the first-ever look at the forthcoming Xenium Analyzer.\n\n \n \n \n \n \n \n\n \n\"Everything we do at 10x Genomics is driven by our belief that in the not-too-distant future, most tissue samples will need to be analyzed using the technologies we're developing across single cell, spatial, and in situ,\" said Ben Hindson, Co-Founder and Chief Scientific Officer of 10x Genomics. \"Our development engine is fired up, innovating, executing, and collaborating to make 2022 the most exciting year of product launches in our history. We're more than ready to build on our track record of over 20 breakthrough technologies as we deliver this year's unparalleled product pipeline.\"\nFor the Chromium single cell platform, Xperience 2022 featured several upcoming products designed to enable broad adoption of single cell methods, remove bottlenecks, and create more value for researchers around the world:\nChromium Fixed RNA Profiling - This kit, which combines an entirely new chemistry and chip with formaldehyde fixation to preserve biological state at the point of collection, enables batching of samples for maximum study flexibility. (Planned to launch in mid-2022.) Chromium Nuclei Isolation - This simple, scalable product answers a major customer request. The kit allows for nuclei isolation from frozen tissues, is easy to use, and requires no expensive instruments (Planned to launch in mid-2022.) Chromium BEAM - Built on top of 10x's existing Immune Profiling product, BEAM (Barcode Enabled Antigen Mapping) will make it possible to perform high-throughput, high-plex, and high-resolution mapping of antigen recognition by B or T cells. (Planned to launch in late 2022.)The single c...